Skip to content
Search AI Powered

Latest Stories

Constitutional Battle Looms as Largest Cannabis Co’s Challenge U.S. Attorney General Over Cannabis Prohibition

The plaintiffs contend that sustaining cannabis prohibition in state markets violates constitutional principles, jeopardizing public safety and depriving licensed cannabis businesses of essential financial benefits granted to other sectors.

MSO's take legal action against U.S. attorney general.
MSO's take legal action against U.S. attorney general.

In a groundbreaking move that has sent ripples across the nation, a coalition of multi-state cannabis businesses or Multi-State Operators (MSO’s) have taken legal action against the U.S. attorney general. The lawsuit, filed by these cannabis companies, aims to halt the federal government from enforcing the longstanding cannabis prohibition on state-sanctioned activities.

Leading the charge are Verano Holdings Corp., Massachusetts' Canna Provisions and Wiseacre Farm, and Treevit CEO Gyasi Sellers. Supporting the lawsuit's foundations are Ascend Wellness Holdings, TerrAscend, Green Thumb Industries, Eminence Capital, and Poseidon Investment Management


The legal firepower backing this endeavor comes from the esteemed law firms Boies Schiller Flexner and Lesser, Newman, Aleo & Nasser LLP, with David Boies, a high-profile litigator, notably at the helm.

The central argument of the lawsuit is compelling and based on the Constitution. The plaintiffs contend that sustaining cannabis prohibition in state markets violates constitutional principles, jeopardizing public safety and depriving licensed cannabis businesses of essential financial benefits granted to other sectors.

Historically, the Controlled Substances Act (CSA) was Congress's vehicle for banning marijuana, aiming to eliminate interstate commerce in the substance. This gave the federal government a reason to enforce prohibition at the state level. However, the lawsuit argues that this stance has been long "abandoned" by both lawmakers and the executive branch, rendering the prohibition an "unjustified vestige."

One of the more alarming issues highlighted is the financial burden and safety concerns state-licensed marijuana businesses face. The lack of access to banking services, credit cards, and particular federal tax deductions—like the notorious IRS code 280E—has forced these businesses to operate primarily in cash. This dependency on cash transactions has unintentionally painted a target on state-regulated dispensaries, leading to an increase in robberies. Such challenges dampen innovation and limit consumer choice.

Furthermore, the attorneys argue that the CSA's stance on cannabis creates an "unconstitutional imposition on state sovereignty." They stress that while Congress has the authority to regulate interstate commerce of marijuana, it shouldn't have the power to control intrastate operations. The lawsuit offers a historical perspective, pointing out that prohibition is a recent stand, coming after a century of sanctioned use and cultivation.

Indeed, the federal perspective on cannabis has been ambiguous, leading to a patchwork of policies. As the lawsuit states, "The federal government has long ago abandoned the goal of eliminating marijuana from commerce."

This inconsistency echoes sentiments expressed by Supreme Court Justice Clarence Thomas in 2021, who criticized the contradictory nature of state-federal cannabis policies. The attorneys emphasize that without the courts' intervention, the CSA will continue hampering states' attempts to establish safe, regulated intrastate marijuana markets, causing irreparable damage to plaintiffs and their communities.

The lawsuit also sheds light on the policy's impact on low-income communities, stressing that current regulations prevent marijuana delivery to public housing facilities in states like Massachusetts. Such restrictions, they argue, are devastating for the industry, especially smaller businesses.

Josh Schiller, a partner at Boies Schiller Flexner, expressed the urgent need to challenge the federal government's stand on cannabis. He hinted at potential future litigation aimed at helping marijuana businesses recoup losses from years of unjust treatment.

Furthermore, David Boies stated that the federal criminalization of marijuana, where it is legally sanctioned by the state, puts unnecessary burdens on legal operations. He called for an updated approach, emphasizing that 38 states have already legalized some form of cannabis.

Amidst this legal battle, there's anticipation around the Drug Enforcement Administration's upcoming review on marijuana scheduling, following a recommendation to shift cannabis from Schedule I to Schedule III under the CSA.

The lawsuit's initiation follows previous hints from cannabis business executives last year about challenging the constitutionality of enforcing cannabis criminalization under the CSA. Many hope that this legal stand will stimulate Congressional action.

In the backdrop of this unfolding drama, the federal government faces other legal challenges related to cannabis, particularly the ban that denies firearm access to marijuana users—a policy some courts have already deemed unconstitutional.

This lawsuit could be the tipping point for cannabis regulation, setting the stage for a constitutional reevaluation that might redefine the future of the industry.

More For You

Masters of Cannabis Marketing is a guest column curated by The Bluntness, Inc., featuring the very best minds in cannabis marketing today.
Masters of Cannabis Marketing is a guest column curated by The Bluntness, Inc., featuring the very best minds in cannabis marketing today.

Is Now the Time for Sports Leagues to Embrace Sponsorship from Cannabis Brands?

Column by Harrison Wise, President of Wise Collective, Inc.

Is Now the Time for Sports Leagues to Embrace Sponsorship from Cannabis Brands?

To quote Bob Dylan, “the times they are a-changing.” Where cannabis and its use were once relegated to the shadows, recent changes in legal status and increases in scientific studies have begun to shift social perception, meaning cannabis, and cannabinoids like CBD, are starting to be embraced by the mainstream. 

Keep ReadingShow less
How much are you paying for your weed?
How much are you paying for your weed?

FAQ: How Much Is A Gram Of Weed? An Ounce?

If you’re new to buying weed, one of the first things to learn is quantities. That’s because at a certain point, there are greater savings that come with buying higher quantities. 

Additionally, sometimes you find a favorite strain, and it’s only available in certain sizes. 

Keep ReadingShow less
Lawmakers in the Empire State are making history in 2021.
Lawmakers in the Empire State are making history in 2021.

Cannabis Legal in New York? Here's What You Need to Know

It's official. On March 31, 2021, New York Gov. Andrew Cuomo signed the Marijuana Revenue and Taxation Act (MRTA) into law.

The historic moment comes after a late-night session where state lawmakers pushed the legislation through. Cuomo had vowed to sign the bill into law immediately, calling it “a major step forward for the Empire State.”

Keep ReadingShow less
Erven's Solonje Burnett & Angela Bacon
Erven's Solonje Burnett & Angela Bacon
Photo: Cindy Trinh 2024 | Erven

Erven Founders Solve Cannabis Industry Problems with Tech and Tenacity

"I remember when I realized how broken communication was in cannabis," recalls Solonje Burnett, Erven co-founder. "A California-based edible brand founder shared how dispensary managers across the state were overwhelmed and consistently not responding to her emails."

This pivotal insight via a chance meeting at NCIA conference in San Francisco in December 2021 marked the genesis of Erven, a startup revolutionizing communication and data-sharing in the evolving cannabis industry.

Keep ReadingShow less
The list of cannabinoids continues to grow.
The list of cannabinoids continues to grow.
Image by Bob G from Pixabay

Answered: WTF is Delta 9 THC-JD (and is it the strongest cannabinoid)?

Scientists are still discovering more plant-based cannabinoids and endogenous cannabinoids which leaves us to wonder how many more are left undiscovered. 

In 2020 alone, scientists discovered over nine novel plant-based cannabinoids, including THCB, CBDB, THCH, CBCH, THCP, CBDP, CBGM, THCM, CBDM, and THCJD. 

Keep ReadingShow less